BlackRock, Inc. 13D and 13G filings for Enanta Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
BLACKROCK INC BLK |
1,673,483 7.800% |
-261,228 (-13.50%) |
Filing |
| 2024-01-24 5:23 pm Sale |
2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
BLACKROCK INC BLK |
1,934,711 9.200% |
-43,300 (-2.19%) |
Filing |
| 2023-10-06 2:34 pm Sale |
2023-09-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
BLACKROCK INC BLK |
1,978,011 9.400% |
-1,775,064 (-47.30%) |
Filing |
| 2023-01-31 3:17 pm Purchase |
2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
BLACKROCK INC BLK |
3,753,075 18.000% |
281,660 (+8.11%) |
Filing |
| 2022-01-28 1:54 pm Purchase |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
BLACKROCK INC BLK |
3,471,415 17.100% |
65,415 (+1.92%) |
Filing |
| 2021-01-25 4:49 pm Purchase |
2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
BLACKROCK INC BLK |
3,406,000 17.000% |
582,432 (+20.63%) |
Filing |